Company Gabidiafil Srl with Fiscal Code 34316122
recorded a turnover of 2024 of
60.090,
with a net profit of
23.978
and having an average number of employees of
1.
The company operates in the field of Activităţi generale de curăţenie a clădirilor having the NACE code 8121.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Gabidiafil Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
7.636
3.282
0
7.126
61.123
58.910
60.560
44.863
56.566
60.090
Total Income - EUR
7.649
4.382
25
7.161
61.334
58.972
60.624
45.130
57.000
60.180
Total Expenses - EUR
10.978
6.129
91
2.131
35.519
29.485
44.490
23.278
31.600
34.266
Gross Profit/Loss - EUR
-3.328
-1.747
-66
5.030
25.815
29.487
16.134
21.852
25.401
25.914
Net Profit/Loss - EUR
-3.557
-1.843
-66
4.815
24.494
28.669
15.601
21.435
24.940
23.978
Employees
1
1
0
1
1
1
2
1
2
1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 6.8%, from 56.566 euro in the year 2023, to 60.090 euro in 2024.
The Net Profit decreased by -822 euro, from 24.940 euro in 2023, to 23.978 in the last year.
Check the financial reports for the company - Gabidiafil Srl
Financial Rating - GABIDIAFIL SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Gabidiafil Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Gabidiafil Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Gabidiafil Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
52.358 euro in 2024 which includes Inventories of
603 euro, Receivables of
0 euro and cash availability of
51.755 euro.
The company's Equity was valued at
48.827 euro, while total Liabilities amounted to
3.531 euro.
Equity increased by 2.728 euro, from 46.358 euro in 2023, to 48.827 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Gabidiafil Srl